University of Toronto, Canada
Studies from Canada, Australia and Japan describe new findings in diabetes research
Published in Physician Law Weekly, August 23rd, 2006
Study 1: Vasodilation may complement renin angiotensin system activation in causing the hyperfiltration state in type 1 diabetes.
According to recent research from Canada, "The initial stages of diabetic nephropathy are characterized by glomerular hyperfiltration and hypertension, processes that have been linked to initiation and progression of renal disease. Renin angiotensin system (RAS) blockade is commonly used to modify the hyperfiltration state and delay progression of renal disease."
"Despite this therapy, many patients progress to ESRD,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2006-08-23)
More Articles from Physician Law Weekly
- Biosite
Biosite notes 45% increase in sales of cardiovascular products - Community Education Centers
Community Education Centers comments on National Institute on Drug Abuse report - J.W.Goethe-Universit-t, Germany
Medico-legal aspects of the use of fentanyl patches discussed - Personnel
HealthSouth names John P. Whittington interim general counsel and corporate secretary - Roche
Court rules in favor of Roche Diagnostics in patent dispute with Enzo Biochem - 3M
3M launches Tegaderm Absorbent Clear Acrylic Dressing for wound care - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
